Can Generic Drugs Be Repurposed for COVID-19 Treatment? episode artwork

EPISODE · Oct 24, 2022 · 11 MIN

Can Generic Drugs Be Repurposed for COVID-19 Treatment?

from Diabetes Discourse

Host: John Buse, MD, PhD Guest: Carolyn Bramante Emerging research has shed light on the possibility of generic drugs being repurposed for the treatment of COVID-19. Dr. John Buse discusses metformin, ivermectin, and fluvoxamine with Dr. Carolyn Bramante, an Assistant Professor in the Division of Geriatrics, Palliative and Primary Care at the University of Minnesota Medical School.

Episode metadata supplied by the publisher feed · Published Oct 24, 2022

Embed this episode

NOW PLAYING

Can Generic Drugs Be Repurposed for COVID-19 Treatment?

0:00 11:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Diabetes Discourse?

This episode is 11 minutes long.

When was this Diabetes Discourse episode published?

This episode was published on October 24, 2022.

Can I download this Diabetes Discourse episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!